As the calendar year progresses, employers that sponsor group health plans should take steps to stay ahead of key midyear compliance obligations. Federal reporting and disclosure requirements under laws such as the Employee Retirement Income Security Act (ERISA), the Consolidated Omnibus Budget Reconciliation Act (COBRA), and the No Surprises Act must be addressed during the … Continued
Key Takeaways From the CAA-mandated Prescription Drug Cost Report The Consolidated Appropriations Act, 2021 (CAA) mandates that group health plans and health insurance issuers submit annual data on premiums, enrollment, medical spending and prescription drug rebates to various departments to address this. This initiative, known as the Prescription Drug Data Collection (RxDC), aims to enhance … Continued
Prescription Drug Report Is Due by June 1, 2024 Group health plans must annually submit detailed information on prescription drug and health care spending to the federal government. This reporting is referred to as the “prescription drug data collection,” or the “RxDC report.” The next RxDC report is due by Saturday, June 1, 2024, covering … Continued
One Huntington Quadrangle
Suite 4N10
Melville, NY 11747
Phone: (631) 465.0606
Email: info@jmbrassillgroup.com
